Display options
Cite
Chattopadyay S. Is oestrogen a 'biological neuroleptic'?. Indian J Psychiatry. 2003;45(4):205-7
Chattopadyay, S. (2003). Is oestrogen a 'biological neuroleptic'?. Indian journal of psychiatry, 45(4), 205-7.
Chattopadyay, Subhagata. "Is oestrogen a 'biological neuroleptic'?." Indian journal of psychiatry vol. 45,4 (2003): 205-7.
Chattopadyay S. Is oestrogen a 'biological neuroleptic'?. Indian J Psychiatry. 2003 Oct;45(4):205-7. PMID: 21206859; PMCID: PMC2952365.
Copy Download .nbib Format: NLM
Share it on

Indian J Psychiatry. 2003 Oct;45(4):205-7.

Is oestrogen a 'biological neuroleptic'?.

Indian journal of psychiatry

Subhagata Chattopadyay

Affiliations

  1. SUBHAGATA CHATTOPADHYAY, B-166, IIT Kharagpur, Kharagpur- 721 302, West Bengal. Tel. No: (03222)- 277054 (R), 282651(R), and 282650 (O). [email protected].

PMID: 21206859 PMCID: PMC2952365

Abstract

OBJECTIVE: Oestrogen-hypothesis in schizophrenia is a largely debated issue. Being a multifactor disorder, schizophrenia has gained importance in the field of psychiatric research, especially to dig out the tentative aetiologies (genetic, biological, environmental etc.), still under tested or not tested. The present article is an attempt only to understand the possible role of oestrogen as a 'core' biological factor at the backdrop of male-female differences (in the onset, course, treatment response, prognosis) in schizophrenia barring other factors. This is to reduce the level of 'conflict' and 'confusion' in the article.

METHOD: Electronic data search is the mainstay of the literature bank, included in the article and only 'supportive' evidences (direct and indirect) are incorporated to understand the role of oestrogen in the brain at the backdrop of schizophrenia.

RESULT: The study comes out with a postulation that oestrogen has got a potential effect in moderating the process of schizophrenia in the females.

CONCLUSION: Oestrogen could be tested as the 'novel' therapeutic agent in the female schizophrenics with the necessary support from the modern Nuclear Imaging Techniques to get maximum therapeutic benefit in schizophrenia.

Keywords: dopamine; oestrogen; schizophrenia; serotonin

References

  1. Gen Hosp Psychiatry. 2002 Sep-Oct;24(5):357-9 - PubMed
  2. Int J Gynaecol Obstet. 2002 Nov;79(2):143-6 - PubMed
  3. Prog Neurobiol. 2001 Jan;63(1):29-60 - PubMed
  4. Cell Mol Neurobiol. 1996 Apr;16(2):199-212 - PubMed
  5. Psychopharmacol Bull. 1997;33(2):221-8 - PubMed
  6. Maturitas. 2002 May 20;42(1):1-12 - PubMed
  7. Synapse. 2000 Jan;35(1):39-44 - PubMed
  8. Behav Brain Res. 1999 Nov 1;105(1):53-68 - PubMed
  9. Clin Exp Pharmacol Physiol. 1998 Oct;25(10):764-75 - PubMed
  10. Brain Res Mol Brain Res. 1998 Aug 31;59(2):205-14 - PubMed
  11. Schizophr Res. 1995 Jul;16(1):25-31 - PubMed
  12. Can J Psychiatry. 2002 Jun;47(5):437-42 - PubMed
  13. Fortschr Neurol Psychiatr. 1992 Jan;60(1):8-16 - PubMed
  14. Cell Mol Neurobiol. 1996 Jun;16(3):325-44 - PubMed
  15. Am J Psychiatry. 2001 Jul;158(7):1134-9 - PubMed
  16. Schizophr Res. 1993 Dec;11(1):41-5 - PubMed
  17. Schizophr Bull. 1994;20(1):203-14 - PubMed
  18. Schizophr Res. 2001 Mar 1;48(1):137-44 - PubMed
  19. Lancet. 1996 Apr 6;347(9006):930-3 - PubMed
  20. J Psychiatry Neurosci. 1997 Jan;22(1):56-60 - PubMed

Publication Types